<DOC>
	<DOCNO>NCT02011841</DOCNO>
	<brief_summary>The aim study evaluate whether long-term rifaximin administration reduce spontaneous bacterial peritonitis recurrence rate cirrhotic patient .</brief_summary>
	<brief_title>Rifaximin Secondary Prevention Spontaneous Bacterial Peritonitis Recurrence Cirrhotic Patients</brief_title>
	<detailed_description>- Rifaximin antibiotic broad-spectrum activity gram-positive gram-negative microorganism , aerobe anaerobes within gastrointestinal tract . The main advantage rifaximin poorly absorbable , minimize antimicrobial resistance adverse event render drug safe patient population . In addition , rifaximin good activity gram-positive organism norfloxacin . - The appreciation potential role enteric flora pathogenesis several gastrointestinal disease broaden clinical use rifaximin , use hepatic encephalopathy , small intestine bacterial overgrowth , inflammatory bowel disease , Clostridium difficile infection . Theoretically , reduce total number gut bacteria , rifaximin could also use achieve intestinal decontamination patient liver cirrhosis ascites , thus prevent spontaneous bacterial peritonitis . - A small retrospective study conclude rifaximin suppresses intestinal bacterial overgrowth , bacterial translocation cirrhotic patient ascites history previous spontaneous bacterial peritonitis episode . Prospective clinical trial warrant evaluate role rifaximin prevention spontaneous bacterial peritonitis recurrence cirrhotic patient .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Patients diagnose cirrhosis base clinical , biochemical , ultrasonographic and/or histological criterion Patients recover episode spontaneous bacterial peritonitis Age &gt; 18 &lt; 80 year 1 . Decompensated cirrhotic patient serum bilirubin &gt; 3.2 mg/dL prothrombin time &lt; 25 % serum creatinine &gt; 3 mg/dL 2 . Active gastrointestinal bleeding 3 . Hepatic encephalopathy &gt; grade 2 4 . Patients clinical , biochemical radiological data suggest hepatocellular carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>liver cirrhosis</keyword>
	<keyword>ascites</keyword>
	<keyword>spontaneous bacterial peritonitis</keyword>
	<keyword>recurrence</keyword>
</DOC>